Company intelligence / Profile preview

IGL Distribution

Lyon, Lyon region, France

Ownership: Private
Development stage: Commercial

Overview

IGL has developed and commercialized several organ preservation solutions and perfusion systems used worldwide in transplantation medicine. Recent launches include RM4 kidney perfusion machine and CE-marked products under MDR regulations.

Therapeutic areas: Immunology
Modalities: DeviceBiologic
Industry: Biotech

Beyond the preview

Go deeper on IGL Distribution.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IGL Distribution.

Explore the full profile